Suppr超能文献

前庭神经鞘瘤伽玛刀放射外科手术后的面神经保留

Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery.

作者信息

Yang Isaac, Sughrue Michael E, Han Seunggu J, Fang Shanna, Aranda Derick, Cheung Steven W, Pitts Lawrence H, Parsa Andrew T

机构信息

Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94143, USA.

出版信息

J Neurooncol. 2009 May;93(1):41-8. doi: 10.1007/s11060-009-9842-3. Epub 2009 May 9.

Abstract

OBJECTIVE

Facial nerve preservation is a critical measure of clinical outcome after vestibular schwannoma treatment. Gamma Knife radiosurgery has evolved into a practical treatment modality for vestibular schwannoma patients, with several reported series from a variety of centers. In this study, we report the results of an objective analysis of reported facial nerve outcomes after the treatment of vestibular schwannomas with Gamma Knife radiosurgery.

MATERIALS AND METHODS

A Boolean Pub Med search of the English language literature revealed a total of 23 published studies reporting assessable and quantifiable outcome data regarding facial nerve function in 2,204 patients who were treated with Gamma Knife radiosurgery for vestibular schwannoma. Inclusion criteria for articles were: (1) Facial nerve preservation rates were reported specifically for vestibular schwannoma, (2) Facial nerve functional outcome was reported using the House-Brackmann classification (HBC) for facial nerve function, (3) Tumor size was documented, and (4) Gamma Knife radiosurgery was the only radiosurgical modality used in the report. The data were then aggregated and analyzed based on radiation doses delivered, tumor volume, and patient age.

RESULTS

An overall facial nerve preservation rate of 96.2% was found after Gamma Knife radiosurgery for vestibular schwannoma in our analysis. Patients receiving less than or equal to 13 Gy of radiation at the marginal dose had a better facial nerve preservation rate than those who received higher doses (<or=13 Gy = 98.5% vs. >13 Gy = 94.7%, P < 0.0001). Patients with a tumor volume less than or equal to 1.5 cm(3) also had a greater facial nerve preservation rate than patients with tumors greater than 1.5 cm(3) (<or=1.5 cm(3) 99.5% vs. >1.5 cm(3) 95.5%, P < 0.0001). Superior facial nerve preservation was also noted in patients younger than or equal to 60 years of age (96.8 vs. 89.4%, P < 0.0001). The average reported follow up duration in this systematic review was 54.1 +/- 31.3 months.

CONCLUSION

Our analysis of case series data aggregated from multiple centers suggests that a facial nerve preservation rate of 96.2% can be expected after Gamma knife radiosurgery for vestibular schwannoma. Younger patients with smaller tumors less than 1.5 cm(3) and treated with lower doses of radiation less than 13 Gy will likely have better facial nerve preservation rates after Gamma Knife radiosurgery for vestibular schwannoma.

摘要

目的

面神经保留是前庭神经鞘瘤治疗后临床疗效的关键指标。伽玛刀放射外科已发展成为一种适用于前庭神经鞘瘤患者的实用治疗方式,多个中心都有相关系列报道。在本研究中,我们报告了对伽玛刀放射外科治疗前庭神经鞘瘤后报道的面神经结果进行客观分析的结果。

材料与方法

通过布尔逻辑在PubMed中检索英文文献,共发现23项已发表的研究,这些研究报告了2204例接受伽玛刀放射外科治疗前庭神经鞘瘤患者的面神经功能可评估和可量化的结果数据。文章的纳入标准为:(1)专门报告了前庭神经鞘瘤的面神经保留率;(2)使用House-Brackmann面神经功能分级(HBC)报告面神经功能结果;(3)记录了肿瘤大小;(4)报告中伽玛刀放射外科是唯一使用的放射外科方式。然后根据所给予的辐射剂量、肿瘤体积和患者年龄对数据进行汇总和分析。

结果

在我们的分析中,伽玛刀放射外科治疗前庭神经鞘瘤后的总体面神经保留率为96.2%。边缘剂量接受小于或等于13 Gy辐射的患者面神经保留率高于接受更高剂量的患者(≤13 Gy = 98.5% 对比 >13 Gy = 94.7%,P < 0.0001)。肿瘤体积小于或等于1.5 cm³ 的患者面神经保留率也高于肿瘤大于1.5 cm³ 的患者(≤1.5 cm³ 为99.5% 对比 >1.5 cm³ 为95.5%,P < 0.0001)。年龄小于或等于60岁的患者面神经保留情况也更佳(96.8% 对比 89.4%,P < 0.0001)。本系统评价中报告的平均随访时间为54.1 ± 31.3个月。

结论

我们对多个中心汇总的病例系列数据的分析表明,伽玛刀放射外科治疗前庭神经鞘瘤后,面神经保留率有望达到96.2%。年龄较小、肿瘤体积小于1.5 cm³ 且接受低于13 Gy较低剂量辐射治疗的患者,伽玛刀放射外科治疗前庭神经鞘瘤后面神经保留率可能更高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验